Biotech Aps Wg - Net Worth and Insider Trading
Biotech Aps Wg Net Worth
The estimated net worth of Biotech Aps Wg is at least $54 Million dollars as of 2024-11-29. Biotech Aps Wg is the Director of Y-mAbs Therapeutics Inc and owns about 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $54 Million. Details can be seen in Biotech Aps Wg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biotech Aps Wg has not made any transactions after 2023-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biotech Aps Wg
Biotech Aps Wg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotech Aps Wg owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Biotech Aps Wg’s form 4 insider trades.
Insider Ownership Summary of Biotech Aps Wg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2023-12-11 | 10 percent owner |
Biotech Aps Wg Latest Holdings Summary
Biotech Aps Wg currently owns a total of 1 stock. Biotech Aps Wg owns 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) as of December 11, 2023, with a value of $54 Million.
Latest Holdings of Biotech Aps Wg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2023-12-11 | 4,552,778 | 11.88 | 54,087,003 |
Holding Weightings of Biotech Aps Wg
Biotech Aps Wg Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotech Aps Wg has made a total of 9 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 5 buys and 4 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the acquisition of 127,549 shares on December 11, 2023, which cost Biotech Aps Wg around $890,292.
Insider Trading History of Biotech Aps Wg
- 1
Biotech Aps Wg Trading Performance
GuruFocus tracks the stock performance after each of Biotech Aps Wg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Aps Wg is 122.39%. GuruFocus also compares Biotech Aps Wg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Aps Wg within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biotech Aps Wg's insider trading performs compared to the benchmark.
Performance of Biotech Aps Wg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.14 | | | | | |
| Relative Return to S&P 500(%) | 4.41 | | | | | |
Biotech Aps Wg Ownership Network
Biotech Aps Wg Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Biotech Aps Wg is the 10 percent owner of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and Sr. VP and COO Joris Wilms .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Biotech Aps Wg made 4 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net purchase of 279,028. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 279,028 shares made by Johan Wedell-wedellsborg , and a net sale of 60,000 shares made by Bo Kruse .
In summary, during the past 3 months, insiders sold 95,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 95,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 558,056 shares were bought by its insiders, resulting in a net sale of 62,310 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Biotech Aps Wg Mailing Address
Above is the net worth, insider trading, and ownership report for Biotech Aps Wg. You might contact Biotech Aps Wg via mailing address: Rungsted Strandvej 113, Rungsted Kyst G7 2960.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
